A randomized controlled study on the effect of glucose-containing dialysate on blood glucose in patients with hemodialysis complicated with type 2 diabetes and a clinical study scheme for the establishment of hypoglycemia warning model

A randomized controlled study on the effect of glucose-containing dialysate on blood glucose in patients with hemodialysis complicated with type 2 diabetes and a clinical study scheme for the establishment of hypoglycemia warning model - Effect of glucose-containing dialysate on type 2 diabetes patients on hemodialysis and establishment of hypoglycemia warning model

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068343

Enrollment

Unknown

Registered

2023-02-15

Start date

2023-02-15

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis complicated with type 2 diabetes

Interventions

Intervention group:Dialysis was performed with a sugary dialysis fluid

The control group :Hemodialysis was performed with a dialysis fluid containing no sugar

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Age=18 years old; ? Patients with end-stage renal disease caused by type 2 diabetes and/or chronic kidney disease complicated with type 2 diabetes; ? Maintenance hemodialysis = 3 months; ? Dialysis time: 3 times/week,4 hours/time; ? Volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: ? Secondary acute complications of diabetes; ? Acute cardiovascular and cerebrovascular events occurred within 3 months before inclusion; ? Severe malabsorption and impaired gastrointestinal motility; ? Serious liver and biliary diseases; ? Acute, infectious or other endocrine diseases that affect blood sugar.

Design outcomes

Primary

Measure	Time frame
blood glucose;Fasting c-peptide and C peptide two hours after meal;Glycated Albumin;	—

Secondary

Measure	Time frame
Analysis of dietary intake of patients;Diabetes Self-management Scale;	—

Countries

China

Contacts

Public ContactLin Chen

West China Hospital, Sichuan University

clhxxuetou@163.com18980601205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026